EPIRUBICINE HIKMA 2 mg/ml, solution intravesical/solution for injection bottle, 100 ml
Active ingredients: Epirubicin hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution or injectable formbottle, 100 mlintraveineuse;intravésicale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EPIRUBICINE HIKMA 2 mg/ml, solution intravésicale/solution injectable
- Pharmaceutical form
- solution ou injectable
- Route of administration
- intraveineuse;intravésicale
- Presentation description
- 1 flacon en verre de 100 mL
- Marketing authorisation holder
- HIKMA FARMACEUTICA (PORTUGAL)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Mar 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60042349CIP75507216CIP133400955072164Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'ÉPIRUBICINEsolution | 2 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.